Esperion Therapeutics, Inc. (NASDAQ:ESPR) Given Consensus Recommendation of “Moderate Buy” by Brokerages
Shares of Esperion Therapeutics, Inc. (NASDAQ:ESPR – Get Free Report) have earned an average rating of “Moderate Buy” from the nine brokerages that are currently covering the firm, Marketbeat.com reports. Four analysts have rated the stock with a hold rating and five have issued a buy rating on the company. The average 1 year target […]
More Stories
Safehold (NYSE:SAFE) Price Target Cut to $24.00 by Analysts at The Goldman Sachs Group
Safehold (NYSE:SAFE – Get Free Report) had its price objective dropped by equities research analysts at The Goldman Sachs Group...
Wedbush Upgrades Shopify (NYSE:SHOP) to Outperform
Wedbush upgraded shares of Shopify (NYSE:SHOP – Free Report) (TSE:SHOP) from a neutral rating to an outperform rating in a...
Brian Anthony Leveille Sells 5,000 Shares of Atlas Energy Solutions Inc. (NYSE:AESI) Stock
Atlas Energy Solutions Inc. (NYSE:AESI – Get Free Report) major shareholder Brian Anthony Leveille sold 5,000 shares of Atlas Energy...
Insider Selling: Permian Resources Co. (NYSE:PR) CFO Sells 8,761 Shares of Stock
Permian Resources Co. (NYSE:PR – Get Free Report) CFO Guy M. Oliphint sold 8,761 shares of the firm’s stock in...
Honey Badger Silver Inc. (CVE:TUF) Senior Officer Buys C$78,000.00 in Stock
Honey Badger Silver Inc. (CVE:TUF – Get Free Report) Senior Officer Chad Williams acquired 600,000 shares of the stock in...
The Ensign Group, Inc. (NASDAQ:ENSG) Director Barry M. Smith Sells 700 Shares
The Ensign Group, Inc. (NASDAQ:ENSG – Get Free Report) Director Barry M. Smith sold 700 shares of the firm’s stock...